EpiCast Report: Gram-Negative Bacterial Pneumonia – Epidemiology
Forecast to 2022

by
GlobalData

Browse more reports on
I...
EpiCast Report: Gram-Negative Bacterial
Pneumonia – Epidemiology Forecast to 2022
Pneumonia is one of the most common infe...
EpiCast Report: Gram-Negative Bacterial
Pneumonia – Epidemiology Forecast to 2022
Scope
The Gram-Negative Bacterial Pneumo...
EpiCast Report: Gram-Negative Bacterial
Pneumonia – Epidemiology Forecast to 2022
For more details contact Mr. Priyank Tiw...
Upcoming SlideShare
Loading in...5
×

EpiCast Report: Gram-Negative Bacterial Pneumonia Market – Epidemiology Forecast to 2022

46

Published on

The Gram-Negative Bacterial Pneumonia EpiCast Report and EpiCast Model provide an overview of the risk factors and epidemiological trends for pneumonia, with a focus on gram-negative bacteria, in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of incident cases of community-acquired pneumonia (CAP) segmented by sex and age (in five-year increments beginning at 0 years and ending at =85 years), incident cases of hospital-acquired pneumonia (HAP), and incident cases of ventilator-associated pneumonia (VAP). Incident HAP cases are further segmented by causative pathogens (Acinetobacter, Escherichia coli, Klebsiella, and Pseudomonas) and antibiotic resistance in these markets.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
46
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

EpiCast Report: Gram-Negative Bacterial Pneumonia Market – Epidemiology Forecast to 2022

  1. 1. EpiCast Report: Gram-Negative Bacterial Pneumonia – Epidemiology Forecast to 2022 by GlobalData Browse more reports on Infectious Diseases Therapeutics Market @ http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals/therapeutics/infectious-diseases-therapeutics . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  2. 2. EpiCast Report: Gram-Negative Bacterial Pneumonia – Epidemiology Forecast to 2022 Pneumonia is one of the most common infectious diseases and is caused by infectious agents such as bacteria, viruses, and fungi. Pneumonia is an acute respiratory infection that inflames the alveoli (air sacs) in the lungs through fluid or pus. The inflamed alveoli causes limited oxygen intake in the lungs and breathing difficulties for individuals, manifesting in symptoms of coughing, chest pain, and fever. Pneumonia is a major public health concern in both developed and developing countries. Chronic diseases such as asthma, chronic obstructive pulmonary disease, and heart disease increase the risk of developing pneumonia. Elderly patients (65 years and older) have twice the incidence of hospital-acquired pneumonia compared with the adult population. Additionally, tobacco smoking has been identified as a cause of pneumonia. In 2012, the 6MM (US, France, Germany, Italy, Spain, UK) had 4,184,449 incident cases of CAP, with 82% of that occurring in the US. By 2022, GlobalData epidemiologists forecast there will be 4,670,664 incident cases of CAP in the 6MM. In Japan, there were 40,043 cases of CAP and HAP with an annual growth rate (AGR) of 3.78%. Complete report available @ http://www.rnrmarketresearch.com/ultrabooks-market-to-2016financial-and-technological-support-from-intel-corporation-coupled-with-demand-from-businessusers-segment-will-drive-growth-market-report.html . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  3. 3. EpiCast Report: Gram-Negative Bacterial Pneumonia – Epidemiology Forecast to 2022 Scope The Gram-Negative Bacterial Pneumonia EpiCast Report and EpiCast Model provide an overview of the risk factors and epidemiological trends for pneumonia, with a focus on gram-negative bacteria, in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast of incident cases of community-acquired pneumonia (CAP) segmented by sex and age (in five-year increments beginning at 0 years and ending at =85 years), incident cases of hospital-acquired pneumonia (HAP), and incident cases of ventilator-associated pneumonia (VAP). Incident HAP cases are further segmented by causative pathogens (Acinetobacter, Escherichia coli, Klebsiella, and Pseudomonas) and antibiotic resistance in these markets. The gram-negative bacterial pneumonia epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM. The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources. Request a sample copy @ http://www.rnrmarketresearch.com/contacts/requestsample?rname=120451 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  4. 4. EpiCast Report: Gram-Negative Bacterial Pneumonia – Epidemiology Forecast to 2022 For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×